Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

3 hrs ago | BioSpace

FDA Approves Use Of Bristol-Myers Squibb Company, Pfizer Inc.'s Eliquis To Treat Leg, Lung Clots

U.S. FDA Approves Eliquis for the Treatment of Deep Vein Thrombosis and Pulmonary Embolism , and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy * Eliquis demonstrated noninferiority in the primary efficacy endpoint of recurrent symptomatic venous thromboembolism or VTE-related death versus enoxaparin/warfarin in the ... (more)

Comment?

Related Topix: Healthcare Law, Law, Biotech, Bristol Myers Squibb, Food and Drug Administration, Medicine, Healthcare Industry, Pfizer, Excaliard Pharmaceuticals

7 hrs ago | Christian Science Monitor

One downside of coprorate inversions: higher tax bills for shareholders

The Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Tax, 401K, Personal Finance

Wed Aug 20, 2014

The Washington Post

AstraZeneca Is Tougher Pfizer Target as Possible New Bid Looms

Pfizer Inc. isn't giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Parsippany, NJ, Business News

BioSpace

Bristol-Myers Squibb Company And Pfizer Inc. To Present New Data On...

Bristol-Myers Squibb Company and Pfizer Inc. announced today that they will present 14 abstracts at the ESC Congress 2014, organized by the European Society of Cardiology, to be held August 30 to September 4 in Barcelona, Spain.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Pfizer, Bloomsbury Publishing, Publishing, Media, Medarex, Foldrx Pharmaceuticals

PR-inside.com

"Pfizer Consumer Healthcare Inc in Consumer Health (USA)" is now available at Fast Market Research

By gaining control of a broad portfolio of OTC brands, Pfizer is better able to fulfil its objective of meeting the health and wellness needs of its consumers at every stage of disease management.

Comment?

Related Topix: Euromonitor International, Advertising, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Healthcare, Medicine, Nutrition

Tue Aug 19, 2014

Business Journal

Hawaii-based Cardax partners with Capsugel to market astaxanthin

Hawaii-based pharmaceutical company Cardax is partnering with major drug capsule manufacturer Capsugel to mass-produce the anti-inflammatory nutritional supplement called astaxanthin.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

Adweek

Publicis N.A. Hires Julie Levin as CMO

Publicis North America CEO Andrew Bruce is rounding out his new executive team with the addition of Julie Levin as chief marketing officer.

Comment?

Related Topix: Marketing, Martin Agency, Advertising, Interpublic Group, Office Equipment, Retail, Global Group of Companies

Customer Interaction Solutions

Manhattan Scientifics Reaches the Fork (Falk) in the Road

Spencer Falk, whose marketing expertise was mission-critical to the blockbuster success of Viagra and Celebrex, among other medical brands, today announced that he would lead the commercialization of early cancer detection technology for Senior Scientific, a division of Manhattan Scientifics .

Comment?

Related Topix: Marketing, Forest Laboratories, Pfizer, Biotech, Medicine, Forest Labs, Healthcare Industry, Oncology

Mon Aug 18, 2014

Customer Interaction Solutions

Pfizer Submits New Drug Application for Palbociclib ; BioBlast...

Below is a look at some of the headlines for companies that made news in the healthcare sector on August 18, 2014.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Food and Drug Administration

Business Insurance

Brand name drugmakers liable for generics: Alabama high court rules again

The Alabama Supreme Court has reaffirmed its controversial ruling that brand-name drugmakers can be held liable for injuries caused by drugs produced by generic manufacturers.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Reglan, Maxolon, Metoclopramide (generic), Heartburn, Health, Healthcare Law, Law, Food and Drug Administration

Forbes.com

Interesting June 2015 Stock Options for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Financial Markets

Thu Aug 14, 2014

Counterpunch

In the Time of the Shadow Bankers

A practice and loophole that emerged around 2008, US corporate tax 'inversions'-the latest version in a long list of US transnational corporation tax scams-have taken off in 2014.

Comment?

Related Topix: Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Benzinga

Pfizer Announces FDA Acceptance Of And Priority Review Designation...

Pfizer Inc. announced today that the U.S. Food and Drug Administration has accepted for review the Biologics License Application for bivalent recombinant LP2086 , the company's vaccine candidate for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in 10 through 25 year olds.

Comment?

Related Topix: Pfizer, Biotech, Food and Drug Administration, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Vaccinations, Health

Scoop

While you were sleeping: Euro-zone GDP stalls

Equities on both sides of the Atlantic advanced amid expectations that central banks will remain more accommodating than previously expected to help spur the pace of recovery and counter the impact of international conflict.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Cisco, Retail, Wal Mart Stores, Stamford, CT

AmericanBankingNews.com

Pfizer PT Lowered to $34.00

Credit Suisse's price target suggests a potential upside of 20.52% from the stock's previous close.

Comment?

Related Topix: Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals

Bloomberg

U.S. Panel Says Seniors Should Get Pfizer's Prevnar 13

Pfizer Inc. won the backing of a key U.S. advisory panel to recommend its vaccine Prevnar 13 for people ages 65 and older to help prevent infections including pneumonia and meningitis.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Centers for Disease Control and Prevention, Control Group, Healthcare Law, Law, US News

Wed Aug 13, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Entre ellos se destacan los principales actores y protagonistas de la i... )--Hecla Mining Company annonce pour le second trimestre une perte nette attribuable aux actionnaires ordinaires de 14,5 millions de dollars, ou 0,04 $ par action.

Comment?

Related Topix: Clickbank, Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Centers for Disease Control and Prevention

Tue Aug 12, 2014

Freshnews

Pfizer Reports Top-line Results from Postherpetic Neuralgia and...

Pfizer Inc. announced today top-line results from two placebo-controlled studies conducted in China with Lyrica in patients with postherpetic neuralgia and painful diabetic peripheral neuropathy , respectively.

Comment?

Related Topix: Lyrica, Pregabalin (generic), Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Marketing

Contract Pharma Breaking News

Cytovance Adds Compliance Directors

Mark Ambrose, Ph.D., has been appointed senior director of Quality Systems and Compliance at Cytovance Biologics and Anne Garstka has been named director of Commercial Compliance.

Comment?

Related Topix: Quality Systems, NextGen Healthcare Information Systems, Exton, PA, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals

Mon Aug 11, 2014

Forbes.com

One Put, One Call Option To Know About for Pfizer

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Excaliard Pharmaceuticals, Foldrx Pharmaceuticals, Financial Markets

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••